MAVIRET is a fully funded hepatitis C prescription medicine on the Pharmaceutical Schedule from 1st February 2019.
Pharmacists are required to complete the MAVIRET ® Quality Use of Medicines course to be enrolled in the AbbVie Care Pharmacy Programme to order and dispense MAVIRET.
If you are interested in participating in the AbbVie Care Pharmacy Programme to supply MAVIRET ® for hepatitis C, go to abbviecarepharmacy.co.nz to register (the username and password are both GT1-6).
If your pharmacy is already registered and participating in the AbbVie Care Pharmacy Programme, enrol and complete the MAVIRET ® Quality Use of Medicines course to supply and advise on this medicine.
This course has been accredited by PSNZ ENHANCE for 2 hours of Group TWO learning and pharmacists may allocate 4 ENHANCE Group TWO points on successful completion of the learning activity.
MAVIRET has an alternative XPHARM distribution arrangement. Under this XPHARM arrangement, the pharmacy does NOT purchase the medicine and cannot claim a dispensing fee in relation to MAVIRET. The pharmacy will receive a service fee.